Core Viewpoint - Microsoft's latest earnings report showed that both revenue and profit exceeded Wall Street expectations, yet the stock price dropped over 12% in intraday trading, resulting in a market cap loss of $430 billion, marking the second-largest single-day market cap loss in U.S. history [2] Financial Performance - For Q2 of fiscal year 2026, Microsoft reported revenue of $81 billion, a 17% year-over-year increase, surpassing market expectations by 1% [5] - Non-GAAP EPS was $4.41, reflecting a 23% year-over-year growth, exceeding market expectations by 5% [5] - Azure cloud business grew by 38% at constant currency, slightly above Wall Street's forecast of 37% [5] Capital Expenditure Concerns - Microsoft's capital expenditure reached $37.5 billion for the quarter, a 66% year-over-year increase, exceeding market expectations by 9% [6] - Investors expressed concerns over the rising capital expenditures, which were expected to drive significant Azure growth that did not materialize immediately [6][8] - Goldman Sachs noted that Microsoft's strategy involves prioritizing first-party applications and internal R&D over short-term Azure revenue growth [6][10] Azure Growth and Capacity Constraints - Microsoft management indicated that Azure is currently facing capacity constraints rather than a lack of demand [13] - Goldman Sachs emphasized that Azure's growth guidance of 37%-38% should be viewed as a reflection of capacity allocation rather than pure demand [13] - If Microsoft had not allocated capacity to first-party applications, Azure's revenue growth could have exceeded 40% [14] AI Product Development - The commercialization path for Copilot is becoming clearer, with a 160% year-over-year increase in M365 Copilot seats, reaching 15 million paid seats [15] - Copilot is expected to have a better customer lifetime value to customer acquisition cost ratio compared to Azure, due to its higher gross margins and customer stickiness [15] Valuation Adjustments - Goldman Sachs adjusted Microsoft's valuation model, lowering the target price from $655 to $600 based on limited visibility on capital expenditure translating into revenue growth [7][16] - Key downside risks include lower-than-expected revenue contributions from the OpenAI partnership, prolonged ramp-up times for internal chip production, and potential leadership changes [16]

Core Viewpoint - Microsoft reported a significant capital expenditure of $37.5 billion in a single quarter, which exceeded market expectations, but this did not lead to a notable acceleration in cloud business growth. The company is prioritizing the allocation of new computing power to self-developed AI products and internal research rather than solely focusing on revenue-generating Azure cloud services, leading to market concerns about short-term capital efficiency and return visibility [1][6]. Financial Performance - In Q2 of FY2026, Microsoft achieved revenue of $81 billion, a year-on-year increase of 17%, surpassing market expectations by 1%. Non-GAAP EPS was $4.41, up 23% year-on-year, exceeding market expectations by 5%. Azure cloud business grew by 38% at constant currency, slightly above Wall Street's forecast of 37% [3][5]. Capital Expenditure Concerns - Investors expressed concerns over Microsoft's rising capital expenditures, which reached $37.5 billion in the quarter, 9% higher than market expectations. The market anticipated that such a substantial investment would lead to a significant acceleration in Azure's growth rate, which did not materialize immediately [6][7]. Strategic Allocation of Resources - Goldman Sachs noted that Microsoft's strategy involves sacrificing short-term Azure revenue growth to prioritize computing power for first-party applications (like Copilot) and internal R&D projects. This strategic choice is expected to drive more meaningful AI positioning and better returns in the medium term [6][7]. Azure Capacity Constraints - Microsoft management indicated that Azure is currently facing capacity limitations rather than a lack of demand. Goldman Sachs emphasized that the guidance for Azure growth of 37%-38% in Q3 should be viewed as a reflection of capacity allocation rather than pure demand. If capacity had not been directed towards first-party applications and internal R&D, Azure's revenue growth rate could have exceeded 40% [8]. Copilot Commercialization - The commercialization path for Copilot is becoming clearer, with adoption and usage accelerating. The number of paid seats for M365 Copilot increased by 160% year-on-year, reaching 15 million. Goldman Sachs believes that Copilot will have a better customer lifetime value to customer acquisition cost ratio compared to Azure, due to its higher gross margins and customer stickiness [9]. Valuation Adjustments - Based on the limited visibility regarding the timeline for capital expenditures to translate into revenue growth, Goldman Sachs adjusted Microsoft's valuation model, lowering the target P/E ratio from 32x to 28x, resulting in a target price reduction to $600. Key downside risks include lower-than-expected revenue contributions from the OpenAI partnership, prolonged ramp-up times for internal chip production, and potential negative impacts from significant leadership changes [10].

Core Insights - Microsoft's Q2 FY2026 earnings report showed revenue and profit exceeding Wall Street expectations, but the stock price faced pressure due to concerns over rising capital expenditures and the pace of cloud business growth [1][3]. Financial Performance - Revenue reached $81 billion, a 17% year-over-year increase, surpassing market expectations by 1% [3]. - Non-GAAP EPS was $4.41, up 23% year-over-year, exceeding market expectations by 5% [3]. - Azure cloud business grew 38% at constant currency, slightly above Wall Street's forecast of 37% [3]. Capital Expenditure Concerns - Capital expenditures for the quarter were $37.5 billion, exceeding market expectations by 9% [3][4]. - Investors are worried that high capital spending has not yet translated into a proportional increase in Azure's growth rate [4]. - Goldman Sachs noted that Microsoft is prioritizing resources for strategic products like Copilot and internal R&D over short-term Azure revenue growth [4]. Azure Capacity Constraints - Microsoft management indicated that Azure is currently facing capacity limitations rather than a lack of demand [5]. - Goldman Sachs emphasized that Azure's growth guidance of 37%-38% for Q3 should be viewed as a reflection of capacity allocation rather than pure demand [5]. - If capacity had not been directed towards first-party applications and internal R&D, Azure's revenue growth could have exceeded 40% [5]. AI Product Development - The commercialization path for Copilot is becoming clearer, with a 160% year-over-year increase in M365 Copilot seats, reaching 15 million paid seats [7]. - Copilot is expected to have a better customer lifetime value to customer acquisition cost ratio compared to Azure, due to higher margins and customer stickiness [7]. - The growth guidance for M365 commercial cloud has slightly slowed to 13%-14%, reflecting the addition of new seats at lower average revenue per user [7]. Valuation Adjustments - Goldman Sachs adjusted Microsoft's valuation model, lowering the target P/E ratio from 32x to 28x, resulting in a target price reduction to $600 [8]. - Key downside risks include lower-than-expected revenue contributions from the OpenAI partnership, prolonged ramp-up times for internal chip production, and potential negative impacts from leadership changes [8].

美东时间1月27日（周二），美股三大指数涨跌不一。受科技股和芯片股提振，标普500指数和纳斯达克综合指数收涨；拖累道琼斯指数收跌，成份股联合 健康集团跌超19%。 道指收跌 截至收盘，标普500指数上涨0.41%，报6978.60点；纳斯达克综合指数上涨0.91%，报23817.10点；道琼斯指数下跌0.83%，报49003.41点。 隔夜美股市场，科技和芯片股走高，提振市场；联合健康集团大跌，拖累道指。国际金价继续攀升，原油价格同步上涨。此外，周三美股盘中，美联储将 宣布今年的首次政策决定，共同关注。 近日，美元指数持续下跌。美国总统特朗普释放美元贬值信号，表示并不担心美元下跌。 关税方面，美国贸易政策持续调整，对印度商品仍维持50%的关税税率，同时威胁将韩国部分商品的关税提高至25%，并要求韩国在数字事务上不要歧视 美国企业。贸易政策的不确定性可能加剧市场对贸易环境的担忧。 此外，周三美股盘中，美联储将宣布今年的首次政策决定。 费城半导体指数收于新高 费城半导体指数上涨2.40%。美光科技涨超5%，科天半导体、应用材料涨超4%，阿斯麦、台积电等均收涨。 据报道，美光科技宣布了一项价值240亿美元的投资计划 ...

【导读】隔夜美股三大指数涨跌不一，美元指数连日下跌 费城半导体指数上涨2.40%。美光科技涨超5%，科天半导体、应用材料涨超4%，阿斯麦、台积电等均收涨。 据报道，美光科技宣布了一项价值240亿美元的投资计划，将在新加坡建设一个新的存储芯片制造厂，以在全球严重短缺的情况下提高产量。新投资将在 未来十年内建立一个先进的晶圆制造工厂，有助于满足市场对NAND存储芯片日益增长的需求，而人工智能和以数据为中心的应用的兴起将为这一需求推 波助澜。美光表示，随着高带宽内存（HBM）成为公司新加坡制造布局的一部分，预计将出现NAND闪存与动态随机存取存储器（DRAM）生产协同效 应的机会。 隔夜美股市场，科技和芯片股走高，提振市场；联合健康集团大跌，拖累道指。国际金价继续攀升，原油价格同步上涨。此外，周三美股盘中，美联储将 宣布今年的首次政策决定，共同关注。 道指收跌 美东时间1月27日（周二），美股三大指数涨跌不一。受科技股和芯片股提振，标普500指数和纳斯达克综合指数收涨；拖累道琼斯指数收跌，成份股联合 健康集团跌超19%。 截至收盘，标普500指数上涨0.41%，报6978.60点；纳斯达克综合指数上涨0.91%，报 ...